Kala pharmaceuticals, inc. (KALA)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Dec'16
Assets
Current assets:
Cash

196,456

85,449

97,556

118,006

138,944

170,898

74,910

91,205

100,525

114,565

122,049

26,350

45,472

Accounts receivable, net

4,794

11,563

7,171

5,648

4,674

-

-

-

-

-

-

-

-

Inventory

-

-

5,557

-

-

-

-

-

-

-

-

-

-

Inventory

5,272

4,648

-

8,219

5,415

4,095

976

-

-

-

-

-

-

Prepaid expenses and other current assets

3,725

3,824

2,202

930

1,416

2,035

4,569

731

889

648

886

1,544

154

Total current assets

210,247

105,484

112,486

132,803

150,449

177,028

80,455

91,936

101,414

115,213

122,935

27,894

45,626

Non-current assets:
Property and equipment, net

2,566

2,698

2,699

2,721

2,849

2,166

1,311

1,250

1,079

786

623

563

594

Long-term inventory

3,821

3,778

3,000

-

-

-

-

-

-

-

-

-

-

Right-of-use assets

29,308

29,781

30,248

30,713

31,143

29,566

131

226

320

413

-

-

-

Restricted cash

12,584

12,582

12,580

12,578

12,575

12,206

2,178

2,178

2,176

134

133

134

109

Total assets

258,526

154,323

161,013

178,815

197,016

220,966

84,075

95,590

104,989

116,546

123,691

28,591

46,329

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable

1,187

2,518

2,162

3,196

2,647

5,446

1,283

2,382

974

1,202

1,135

1,325

997

Accrued expenses and other current liabilities

14,711

20,929

14,555

12,878

10,335

11,101

7,968

5,146

3,698

6,606

3,938

4,303

3,993

Current portion of lease liabilities

1,375

1,327

1,279

1,627

1,620

463

101

202

300

397

-

-

-

Current portion of long-term debt

-

-

-

-

-

-

3,333

1,667

-

6,667

6,111

2,222

556

Total current liabilities

17,273

24,774

17,996

17,701

14,602

17,010

12,685

9,397

4,972

14,872

11,184

7,850

5,546

Long-term liabilities:
Long-term lease liability - less current portion

28,305

28,673

29,026

29,356

29,590

28,752

-

-

-

-

-

-

-

Long-term debt

71,438

71,184

70,935

70,692

70,457

70,226

16,456

18,100

19,746

11,987

13,629

7,488

9,098

Warrant liability

-

-

-

-

-

-

-

-

-

-

0

2,260

1,039

Other long-term liabilities

-

-

-

-

-

-

-

-

-

8

15

21

17

Total long-term liabilities

99,743

99,857

99,961

100,048

100,047

98,978

16,456

18,100

19,746

11,995

13,644

9,769

10,154

Total liabilities

117,016

124,631

117,957

117,749

114,649

115,988

29,141

27,497

24,718

26,867

24,828

17,619

15,700

Commitments and Contingencies (Note 12)

-

-

-

-

-

-

0

0

0

-

0

0

0

Stockholders' equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized as of December 31, 2018 and December 31, 2017; no shares issued or outstanding as of December 31, 2018 or December 31, 2017

-

-

-

-

-

-

0

0

0

-

-

-

0

Common stock, $0.001 par value; 120,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 54,585,636 and 36,086,254 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

55

36

35

34

34

34

25

25

25

25

24

1

1

Additional paid-in capital

458,866

325,112

316,519

311,354

308,830

306,053

230,799

228,355

225,914

224,025

221,920

5,485

4,374

Accumulated deficit

-317,411

-295,456

-273,498

-250,322

-226,497

-201,109

-175,890

-160,287

-145,668

-134,371

-123,081

-112,905

-92,137

Total stockholders' equity

141,510

29,692

43,056

61,066

82,367

104,978

54,934

68,093

80,271

89,679

98,863

-107,419

-87,762

Total liabilities and stockholders' equity

258,526

154,323

161,013

178,815

197,016

220,966

84,075

95,590

104,989

116,546

123,691

28,591

46,329